DrugPatentWatch Database Preview
Acerus Company Profile
» See Plans and Pricing
What is the competitive landscape for ACERUS, and when can generic versions of ACERUS drugs launch?
ACERUS has one approved drug.
There are four US patents protecting ACERUS drugs.
There are twenty-four patent family members on ACERUS drugs in twenty-one countries.
Summary for Acerus
| International Patents: | 24 |
| US Patents: | 4 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Acerus
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acerus | NATESTO | testosterone | GEL, METERED;NASAL | 205488-001 | May 28, 2014 | RX | No | No | 8,877,230 | Start Trial | Start Trial | ||||
| Acerus | NATESTO | testosterone | GEL, METERED;NASAL | 205488-001 | May 28, 2014 | RX | No | No | 8,574,622 | Start Trial | Y | Start Trial | |||
| Acerus | NATESTO | testosterone | GEL, METERED;NASAL | 205488-001 | May 28, 2014 | RX | No | No | 8,784,882 | Start Trial | Y | Start Trial | |||
| Acerus | NATESTO | testosterone | GEL, METERED;NASAL | 205488-001 | May 28, 2014 | RX | No | No | 8,784,869 | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Acerus Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Brazil | PI0416370 | Start Trial |
| Russian Federation | 2331423 | Start Trial |
| Canada | 2541498 | Start Trial |
| Norway | 338665 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
